BGI (Beijing Genomics Institute) and Covaris, Inc. today announced a deal that will integrate Covaris' Adaptive Focused Acoustics™ AFA™ DNA shearing technology across several BGI laboratories in China. BGI will utilize the Covaris LE220 parallel processing, multi-sample platform to fragment DNA samples for Next-Generation Sequencing.
"BGI will use Covaris instrumentation and consumables in our DNA library construction process. Our laboratories will process a large volume of samples on a daily basis, so the multi-sample format provided by the LE220 was a key consideration for us," said Mr. Wu of BGI. "The Covaris LE220 instrument offers both high-throughput capability and consistent high-quality results for our downstream applications."
"Beijing Genomics Institute is a recognized world leader in the field of genomic research, and Covaris is delighted to be working together with BGI to provide researchers with high-throughput Next Generation sample preparation," said Jim Laugharn, Covaris President and CEO. "High quality, reproducible sample preparation is the critical first step in improving down-stream analytical results. The unique and highly controlled Covaris systems set the standard for today's rapidly advancing analytical technologies and sophisticated assays. For example, isothermal Covaris processes will be beneficial for proteomic-related studies such as ChIP."
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare